Stockreport

Enlivex Receives Notice of Allowance for Chinese Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis [Yahoo! Finance]

Enlivex Therapeutics Ltd. - Ordinary Shares  (ENLV) 
PDF clinical-stage macrophage reprogramming immunotherapy company, today announced that the China National Intellectual Property Administration (CNIPA) issued a notice of al [Read more]